Recombinant Monoclonal anti-D in Tanzania: NEMLIT level, who can prescribe it and STG references
Recombinant Monoclonal anti-D is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level C (council or district hospital). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 1 section.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is recombinant Monoclonal anti-D available on the DukaDawa pharmacy network?
Not yet. Recombinant Monoclonal anti-D is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is recombinant Monoclonal anti-D on the NEMLIT, and who can prescribe it?
Yes. Recombinant Monoclonal anti-D is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level C (council or district hospital). At level C it may be prescribed by specialists, medical officers, dental officers and assistant medical officers.
- Level
- C (council or district hospital)
- Category
- Sera and Immunoglobulins (Immunological agents)
- Listed forms
- Injection 300mcg/mL
- Page
- NEMLIT, p. 23
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C (listed) | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is recombinant Monoclonal anti-D in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention recombinant Monoclonal anti-D in 1 section, most often section 22.2.5.1 Gynecological Malignancies > Gestational Trophoblastic Disease > Premalignant gestational trophoblastic disease (p. 574). See the STG for treatment details.
- 22.2.5.1 Gynecological Malignancies > Gestational Trophoblastic Disease > Premalignant gestational trophoblastic disease, p. 574
Sections that mention Recombinant Monoclonal anti-D, most mentions first. Positions only: see the STG for treatment details.
Related medicines
- Diphtheria antitoxinNEMLIT A · Not on the DukaDawa network yet
- Human rabies immunoglobulin (HRIG)NEMLIT B · Not on the DukaDawa network yet
- Scorpion antivenom immunoglobulinNEMLIT A · Not on the DukaDawa network yet
- Snake Venom AntiserumNEMLIT A · Not on the DukaDawa network yet
- Tetanus ImmunoglobulinNEMLIT A · Not on the DukaDawa network yet
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.